Nippon Zoki Pharmaceutical Co., Ltd.
Records under this name other than the patents Nippon Zoki Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
Back to Nippon Zoki Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,780,133 | A Method for Protecting Liver and a Liver Protecting Agent Formerly held In force · High confidence | In force | High confidence | |
| US 12,016,959 | Sustained Drug Release Sheet for Treating Nerve Injury Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 11,464,762 | Carcinogenesis Inhibitor Lapsed on the fee record Ended Oct 11, 2026 · High confidence | Lapsed on the fee record | Ended Oct 11, 2026 | High confidence |
| US 11,458,102 | Acetaminophen Preparation, and Method for Producing Same Lapsed on the fee record Ended Oct 4, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 4, 2026 | Medium confidence |
| US 11,433,031 | Method for Manufacturing Acetaminophen Preparation Lapsed on the fee record Ended Sep 6, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 6, 2026 | Medium confidence |
| US 8,653,285 | Aminopropylidene derivative Lapsed on the fee record Ended Feb 18, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2026 | USPTO record |
| US 9,884,077 | Extract and preparation containing said extract Lapsed on the fee record Ended Feb 6, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | USPTO record |
| US 8,640,873 | Plastic ampule Lapsed on the fee record Ended Feb 4, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2026 | USPTO record |
| US 8,613,962 | Prophylactic or Alleviating Agent for Peripheral Nerve Disorder Induced by Anti-Cancer Agent Lapsed on the fee record Ended Dec 24, 2025 · High confidence | Lapsed on the fee record | Ended Dec 24, 2025 | High confidence |
| US 9,801,858 | Progress-supressing or improving agent for chronic kidney disease Lapsed on the fee record Ended Oct 31, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | USPTO record |